For pharmaceutical injury cases, many states apply a "discovery rule," meaning the clock starts when you discovered (or reasonably should have discovered) that the medication caused your injury, not necessarily when the injury first occurred
Zogzas and Mukhopadhyay, 2018)
Last but not least first GLP1 FDA approved molecule came in 2005 and ZYOG1 was first oral molecules in phase trial, I was just wondering why Zydus did not tried to do injectable knowing poor bioavailability of Peptide drugs
The solution may look fine after thawing, but the semaglutide molecules can be denatured beyond function
Learn more directly from the FDA: Comment BIOHACK if you want more science and health news like this
Clinical dosing programs in other drug areas show that at the intermediate dosage stage, 50% of patients experienced mild side effects